User:SwimmingNathan/sandbox
Company type | Private |
---|---|
Industry | Biotechnology |
Founded | 2012 |
Headquarters | Cambridge, United Kingdom |
Key people | Prof. Shankar Balasubramanian, Ph.D. (Co-Founder and Director) Bobby Yerramilli-Rao(Co-Founder and Director) |
Products | TrueMethyl oxidative bisulfite sequencing (oxBS-seq) |
Website | http://www.cambridge-epigenetix.com |
Cambridge Epigenetix Ltd (CEGX) is a start-up biosciences company that manufactures epigenetic tools[1][2][3][4]. CEGX supply TrueMethyl® oxidative bisulfite sequencing (oxBS-Seq) kits, which involve a technology that enables quantitative, single-base resolution sequencing of the modified bases 5-hydroxymethylcytosine (5-hmC) and methylcytosine (5-mC)[5][6][7].
The technology was Co-invented by Prof. Shankar Balasubramanian, who previously co-invented the Solexa / Illumina sequencing-by-synthesis platform, and Michael Booth[8]. The technology was unveiled in a published paper in May 2012. The company started commercially shipping products as of August 2013.
Cambridge Epigenetix have also sponsored two events aimed at promoting and encouraging discussion of Epigenetics[9][10][11].
References
[edit]- ^ http://www.enterprise.cam.ac.uk/industry/equity-portfolio/c/cambridge-epigenetix/
- ^ http://www.enterprise.cam.ac.uk/news/2013/7/cambridge-epigenetix-launches-its-first-product/
- ^ http://www.news-medical.net/news/20130903/Cambridge-Epigenetixe28099s-pioneering-TrueMethyle284a2-kit-proves-successful-in-beta-trial.aspx
- ^ http://www.cambridge-news.co.uk/Business/Business-News/Cambridge-University-spin-out-Epigenetix-helps-to-unravel-next-chapter-in-gene-story-20131029135830.htm
- ^ http://www.genomeweb.com/sequencing/startup-cambridge-epigenetix-commercialize-oxbs-technology
- ^ http://www.babraham.ac.uk/news2013/jul11.html
- ^ http://www.genengnews.com/new-products/kits-for-analyzing-modified-cytosines/5008/
- ^ Booth MJ; et al. (May 2012). "Quantitative Sequencing of 5-Methylcytosine and 5-Hydroxymethylcytosine at Single-Base Resolution". Science. 336 (6083): 934–937. doi:10.1126/science (inactive 2023-08-02). PMID 22539555.
{{cite journal}}
:|first2=
missing|last2=
(help);|first3=
missing|last3=
(help);|first4=
missing|last4=
(help);|first5=
missing|last5=
(help);|first6=
missing|last6=
(help);|first7=
missing|last7=
(help); Explicit use of et al. in:|author=
(help)CS1 maint: DOI inactive as of August 2023 (link) CS1 maint: date and year (link) - ^ http://www.cuh.org.uk/addenbrookes/health_professionals/paediatric_gastroenterology_masterclass/epigenetics_workshop.html
- ^ http://talks.cam.ac.uk/show/index/24992
- ^ http://www.cambridge-epigenetix.com/en_US/news/13/cegx-is-a-new-co-sponsor-of-the-cambridge-epigenetics-club